Metallaphosphinidene Coupling with a Phosphorus Ylide to Form a Phosphavinyl [P═CH 2 ] − Ligand
Journal of the American Chemical Society · 24.06.2026 · 148 (24) · 25096-25106
DOI: 10.1021/jacs.6c06304 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Chemical Society, online erschienen am 08.06.2026. Verfasst von Mattias Tan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Lund University, Naturvetarvägen 22, Lund 22100, Sweden. Die Arbeit nennt 123 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Vetenskapsr?det, Crafoordska Stiftelsen, Rice University.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Chemistry, Lund University, Naturvetarvägen 22, Lund 22100, Sweden.
- Department of Chemical and Biomolecular Engineering, Rice University, 6100 Main Street, Houston, Texas 770052, United States.
ORCID-Profile: Mattias Tan, Christian Sandoval-Pauker, Zoltan Takacs, Anders Reinholdt
Förderung
- Vetenskapsr?det
- Crafoordska Stiftelsen
- Rice University
- Maja and Erik Lindqvist Foundation
Zitieren
APA
Tan, M., Sandoval-Pauker, C., Takacs, Z., & Reinholdt, A. (2026). Metallaphosphinidene Coupling with a Phosphorus Ylide to Form a Phosphavinyl [P═CH 2 ] − Ligand. Journal of the American Chemical Society, 148(24), 25096-25106. https://doi.org/10.1021/jacs.6c06304
Vancouver
Tan M, Sandoval-Pauker C, Takacs Z, Reinholdt A. Metallaphosphinidene Coupling with a Phosphorus Ylide to Form a Phosphavinyl [P═CH 2 ] − Ligand. Journal of the American Chemical Society. 2026;148(24):25096-25106. doi:10.1021/jacs.6c06304
BibTeX
@article{Tan2026,
author = {Tan, Mattias and Sandoval-Pauker, Christian and Takacs, Zoltan and Reinholdt, Anders},
title = {Metallaphosphinidene Coupling with a Phosphorus Ylide to Form a Phosphavinyl [P═CH 2 ] − Ligand},
journal = {Journal of the American Chemical Society},
year = {2026},
volume = {148},
number = {24},
pages = {25096--25106},
doi = {10.1021/jacs.6c06304}
}
EUVIMED